Hubei Kangnong Seed (837403)

Search documents
康农种业(837403) - 第三届董事会第二十四次会议决议公告
2025-04-29 15:56
第三届董事会第二十四次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 (一)会议召开情况 1.会议召开时间:2025 年 4 月 25 日 2.会议召开地点:公司会议室 3.会议召开方式:本次会议采用现场和通讯相结合的方式 证券代码:837403 证券简称:康农种业 公告编号:2025-031 湖北康农种业股份有限公司 4.发出董事会会议通知的时间和方式:2025 年 4 月 15 日以通讯方式发出 5.会议主持人:董事长方燕丽女士 6.会议列席人员:监事及高级管理人员 7.召开情况合法、合规、合章程性说明: 本次会议的召集、召开、议案审议程序均符合《中华人民共和国公司法》和 《湖北康农种业股份有限公司章程》的规定,所作决议合法有效。 (二)会议出席情况 会议应出席董事 9 人,出席和授权出席董事 9 人。 二、议案审议情况 (一)审议通过《关于<2024 年度总经理工作报告>的议案》 1.议案内容: 2024 年度,公司管理团队在董事会领导下,本着对公司和股东高度 ...
康农种业(837403) - 2024年年度权益分派预案公告
2025-04-29 15:55
837403 2025-035 2024 2024 2025 4 29 2024 2024 12 31 208,181,513.59 200,858,600.85 180,333,859.08 180,213,859.08 120,000.00 70,972,200 10 2.00 10 4 10 4 10 0 14,194,440.00 28,388,880 2025 4 25 2024 3 0 0 2024 3 0 0 10% 50% 25% 2 3 1 50% 2 30% 1 1 10% 2 2 10% 3 1 80% 2 40% 3 20% 1234212 2023 3 15 http://www.neeq.com.cn 2023-042 2024 2 2025 4 29 ...
康农种业(837403) - 关于湖北康农种业股份有限公司非经营性资金占用及其他关联资金往来情况的专项说明
2025-04-29 15:22
中喜专审 2025Z00379 号 关于湖北康农种业股份有限公司 非经营性资金占用及其他关联资金往来情况的 专项说明 中喜会计师事务所(特殊普通合伙) 地址:北京市东城区崇文门外大街11号新成文化大厦A座11层 邮编:100062 电话:010-67085873 传真:010-67084147 邮箱:zhongxi@zhongxicpa.net 目录 | | | | 一、关于湖北康农种业股份有限公司非经营性资金占用及其 | 1-2 | | --- | --- | | 他关联资金往来情况的专项说明 | | | 二、湖北康农种业股份有限公司非经营性资金占用及其他关 | 3 | 联资金往来情况汇总表 三、会计师事务所营业执照及资质证书 中 喜 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) ZHONGXI CPAs(SPECIAL GENERAL PARTNERSHIP) 关于湖北康农种业股份有限公司 地址:北 京 市 崇 文 门 外 大 街 11号 新 成 文 化 大 厦 A座 11层 电话:010-67085873 传真:010-67084147 邮政编码:100062 1 非经营性资金占用及其他关联资金 ...
康农种业(837403) - 第一创业证券承销保荐有限责任公司关于湖北康农种业股份有限公司2024年度募集资金存放与实际使用情况的核查意见
2025-04-29 15:22
第一创业证券承销保荐有限责任公司 关于湖北康农种业股份有限公司 2024 年度募集资金存放与实际使用情况的核查意见 第一创业证券承销保荐有限责任公司(以下简称"一创投行"或"保荐机构") 作为湖北康农种业股份有限公司(以下简称"康农种业"或"公司")向不特定 合格投资者公开发行股票并在北交所上市的保荐机构。根据《北京证券交易所上 市公司持续监管办法(试行)》《北京证券交易所股票上市规则》和《北京证券交 易所持续监管指引第 9 号——募集资金管理》等有关法律法规和规范性文件的要 求,对公司 2024 年度募集资金存放与实际使用情况进行专项核查,并出具如下 核查意见: 一、募集资金基本情况 湖北康农种业股份有限公司(以下简称"公司")向不特定合格投资者公开 发行股票并在北京证券交易所上市的申请于 2023 年 12 月 18 日经中国证券监督 管理委员会批复同意注册(证监许可〔2023〕2839 号)。经北京证券交易所于 2024 年 1 月 15 日出具的《关于同意湖北康农种业股份有限公司股票在北京证券交易 所上市的函》(北证函〔2024〕44 号)批准,公司股票于 2024 年 1 月 18 日在北 京证券交 ...
康农种业(837403) - 内部控制审计报告
2025-04-29 15:22
湖北康农种业股份有限公司 内部控制审计报告 中喜专审 2025Z00378 号 中喜会计师事务所(特殊普通合伙) 地址:北京市东城区崇文门外大街11号新成文化大厦A座11层 邮编:100062 电话:010-67085873 传真:010-67084147 邮箱:zhongxi@zhongxicpa.net 目录 | 内 | 容 | 页 次 | | --- | --- | --- | | 一、内部控制审计报告 | | 1-2 | | 二、内部控制自我评价报告 | | 1-7 | 三、会计师事务所营业执照及资质证书 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的有效性发表审 计意见,并对注意到的非财务报告内部控制的重大缺陷进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性,存在不能防止和发现错报的可能性。此外,由于情 况的变化可能导致内部控制变得不恰当,或对控制政策和程序遵循的程度降低,根 据内部控制审计结果推测未来内部控制的有效性具有一定风险。 中 喜 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) ZHONGXI CPAs(SPECIAL GENERAL PA ...
康农种业(837403) - 关于湖北康农种业股份有限公司募集资金 2024 年度存放与使用情况鉴证报告
2025-04-29 15:22
地址:北京市东城区崇文门外大街11号新成文化大厦A座11层 邮编:100062 电话:010-67085873 传真:010-67084147 邮箱:zhongxi@zhongxicpa.net 目录 | 内 容 | 页 次 | | --- | --- | | 一、关于湖北康农种业股份有限公司募集资金年度存放与使 | 1-2 | | 用情况鉴证报告 | | | 二、湖北康农种业股份有限公司关于募集资金年度存放与使 | 1-3 | | 用情况的专项报告 | | 三、会计师事务所营业执照及资质证书 关于湖北康农种业股份有限公司 募集资金 2024 年度存放与使用情况 鉴证报告 中喜特审 2025T00211 号 中喜会计师事务所(特殊普通合伙) 中 喜 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) ZHONGXI CPAs(SPECIAL GENERAL PARTNERSHIP) 关于湖北康农种业股份有限公司 募集资金2024年度存放与使用情况鉴证报告 中喜特审2025T00211号 湖北康农种业股份有限公司全体股东: 我们接受委托,对后附的湖北康农种业股份有限公司(以下简称康农种业公司) 董事会编制的2 ...
康农种业(837403) - 2024年度审计报告
2025-04-29 15:22
湖北康农种业股份有限公司 审计报告 中喜财审 2025S01856 号 中喜会计师事务所(特殊普通合伙) 地址:北京市东城区崇文门外大街11号新成文化大厦A座11层 邮编:100062 电话:010-67085873 传真:010-67084147 邮箱:zhongxi@zhongxicpa.cn 中 喜 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) ZHONGXI CPAs(SPECIAL GENERAL PARTNERSHIP) 审 计 报 告 中喜财审2025S01856号 湖北康农种业股份有限公司全体股东: 一、审计意见 我们审计了湖北康农种业股份有限公司(以下简称"康农种业公司")财务报 表,包括2024年12月31日的合并及母公司资产负债表,2024年度的合并及母公司利 润表、合并及母公司现金流量表、合并及母公司股东权益变动表以及相关财务报表 附注。 我们认为,后附的财务报表在所有重大方面按照企业会计准则的规定编制,公 允反映了康农种业公司2024年12月31日的合并及母公司财务状况以及2024年度的合 并及母公司经营成果和现金流量。 二、形成审计意见的基础 我们按照中国注册会计师审计准则 ...
康农种业(837403) - 2025 Q1 - 季度财报
2025-04-29 15:01
Financial Performance - Operating revenue for Q1 2025 was CNY 24,298,661.55, down 29.11% from CNY 34,275,554.02 in the same period last year[11] - Net profit attributable to shareholders was a loss of CNY 887,474.06, representing a decline of 108.72% compared to a profit of CNY 10,180,355.88 in Q1 2024[11] - The net profit for Q1 2025 was a loss of CNY 887,474.06, compared to a profit of CNY 11,492,136.80 in Q1 2024, marking a significant decline[39] - Operating profit for Q1 2025 was a loss of CNY 1,037,240.63, compared to a profit of CNY 4,523,864.65 in Q1 2024[39] - Total revenue for Q1 2025 was CNY 24,298,661.55, a decrease from CNY 34,275,554.02 in Q1 2024, representing a decline of approximately 29%[38] - Total operating costs for Q1 2025 were CNY 26,827,981.58, down from CNY 33,383,479.58 in Q1 2024, indicating a reduction of about 20%[38] - The basic earnings per share for Q1 2025 was -CNY 0.01, down from CNY 0.16 in Q1 2024[40] - Other income for Q1 2025 was CNY 2,139,574.75, compared to CNY 4,128,836.83 in Q1 2024, indicating a decrease of approximately 48%[38] Cash Flow - The net cash flow from operating activities was negative CNY 119,912,281.22, a decrease of 728.33% from negative CNY 14,476,421.59 in the previous year[11] - Cash flow from operating activities in Q1 2025 was a net outflow of CNY 119,912,281.22, compared to a net outflow of CNY 14,476,421.59 in Q1 2024[44] - The total cash inflow from investment activities in Q1 2025 was CNY 101,708.31, while cash outflow was CNY 11,305,006.37, resulting in a net cash outflow of CNY 11,203,298.06[45] - The company experienced a significant cash flow deficit in operating and investing activities, impacting overall financial health[47] - The net increase in cash and cash equivalents was -$90.48 million, contrasting with a positive increase of $106.88 million in the prior period[47] - The ending balance of cash and cash equivalents stood at $109.81 million, down from $187.74 million, reflecting liquidity challenges[47] Assets and Liabilities - Total assets decreased by 5.06% to CNY 861,434,797.75 compared to the end of the previous year[11] - Total current assets decreased to CNY 689,000,025.75 as of March 31, 2025, from CNY 733,256,649.92 on December 31, 2024, representing a decline of approximately 6.0%[31] - Total liabilities decreased to CNY 374,837,661.66 as of March 31, 2025, from CNY 419,856,665.06 on December 31, 2024, representing a decline of approximately 10.7%[33] - Total equity remained relatively stable at CNY 486,597,136.09 as of March 31, 2025, compared to CNY 487,484,610.15 on December 31, 2024, showing a minor decrease of about 0.2%[33] - The company reported a total of CNY 62,129,162.43 in accounts payable as of March 31, 2025, down from CNY 109,401,447.69 on December 31, 2024, indicating a decrease of about 43.1%[32] Inventory and Accounts Receivable - Inventory increased by 46.46% to CNY 271,946,776.95 due to the 2024 seed production storage[12] - Accounts receivable increased to CNY 201,150,013.71 as of March 31, 2025, compared to CNY 190,675,724.90 on December 31, 2024, reflecting an increase of about 5.0%[31] - Inventory rose significantly to CNY 271,946,776.95 as of March 31, 2025, up from CNY 185,685,549.05 on December 31, 2024, indicating a growth of approximately 46.4%[31] Shareholder Information - The total number of ordinary shareholders was 3,504 as of the report date[18] - The largest shareholder, Fang Yanli, holds 36,595,000 shares, representing 51.56% of the total shares[19] - The total shares held by the top ten shareholders amount to 47,395,783, which is 66.78% of the total shares[20] Legal and Commitments - The company has ongoing litigation with a total amount of 2,912,200, accounting for 0.60% of the net assets[24] - All disclosed commitments are being fulfilled normally as of the report date[26] Related Party Transactions - The company’s related party transactions with Ningxia Kangnong are expected to include approximately 15.5 million for 2024 seed procurement[25]
康农种业(837403) - 2024 Q4 - 年度财报
2025-04-29 14:56
Capital Structure and Shareholder Information - The total share capital of Hubei Kangnong Seed Co., Ltd. is 70,972,200 shares after a recent increase from 54,594,000 shares due to a stock dividend distribution[20]. - The company reported a significant increase in registered capital, which rose to 70,972,200 yuan following the issuance of 15,134,000 shares to unspecified qualified investors[19]. - The total number of ordinary shares increased from 39,460,000 to 70,972,200 after a public offering and subsequent stock dividend[136]. - The largest shareholder, Fang Yanli, holds 36,595,000 shares, representing 51.56% of the total shares[137]. - The controlling shareholder, Fang Yanli, holds 51.56% of the company's shares, ensuring significant control over company decisions[142]. - The total number of ordinary shareholders is 3,409[135]. - The company’s core employees hold 598,449 shares, which is 0.84% of the total shares[135]. - The total number of shares to be increased through the profit distribution plan is 16,378,200 shares, which aligns with the company's profit distribution policy[155]. Financial Performance - Net profit attributable to shareholders reached ¥82,599,891.43, marking a 55.21% growth from the previous year[27]. - Operating income grew to ¥336,657,483.70, representing a 16.80% increase compared to 2023[27]. - The company's gross profit margin improved to 35.79%, up from 30.73% in the previous year[27]. - Total assets increased to ¥907,341,275.21, a growth of 68.38% compared to the end of 2023[26]. - Total liabilities rose to ¥419,856,665.06, reflecting a 57.82% increase year-over-year[26]. - The company's cash and cash equivalents increased by 189.24% to CNY 252.46 million, primarily due to funds raised from the IPO and improved sales collection[51]. - The company achieved operating revenue of CNY 336.66 million, a year-on-year increase of 16.80%[42]. - The company reported a net profit of CNY 83.24 million in 2024, representing a 55.09% increase compared to CNY 53.67 million in 2023[56]. Research and Development - The company has established a biological breeding research institute, indicating a focus on innovation and research in agricultural biotechnology[14]. - R&D expenditure for the period was CNY 14,376,588.99, accounting for 4.27% of operating income, an increase from 3.73% in the previous year[86]. - The total number of R&D personnel decreased from 21 to 20, while the proportion of R&D personnel to total employees increased from 13.79% to 19.09%[83]. - The company holds 38 patents, down from 63 in the previous period, with 6 of them being invention patents[84]. - The company is conducting a project on tropical corn, which has been completed and is expected to enhance market coverage in tropical regions[85]. - The company plans to focus on developing high-yield and resilient corn varieties to enhance food security in China[47]. Market Expansion and Sales Strategy - The company has plans for market expansion and product development, although specific future projections were not detailed in the report[11]. - The company plans to accelerate market expansion in the Huang-Huai-Hai and East North China regions by increasing seed production area and promoting quality varieties[105]. - The company aims to explore international markets and seek overseas partners to promote its products and services globally[105]. - The company is focusing on technological innovation in breeding research, establishing major research platforms, and introducing high-level talent[108]. - The marketing strategy includes consolidating its position in the Southwest, expanding into new markets, and enhancing online marketing efforts to increase product visibility and sales[108]. Governance and Risk Management - The company has a robust financial oversight structure, with a dedicated board of supervisors and management team ensuring accountability[10]. - The company emphasizes risk management, with a section in the report dedicated to analyzing major risk factors that could impact operations[12]. - The company has established a governance structure to mitigate risks associated with the actual controller's influence on major decisions, ensuring the protection of minority shareholders' interests[113]. - The company has not reported any significant changes in risk factors during the reporting period, indicating stable operational conditions[114]. - The company has implemented a scientific dealer management system to mitigate risks associated with a growing number of distributors[110]. Employee and Management Structure - The total number of employees increased from 110 to 145, reflecting a 31.8% growth in workforce[170]. - The total number of management personnel increased from 17 to 24, a 41.2% increase[170]. - The total number of production personnel increased from 35 to 58, a 65.7% increase[170]. - The company has established new governance systems, including the "Investment Management System" and "Public Opinion Management System," to enhance operational standards[182]. - The company has appointed new independent directors to enhance governance structure, with one leaving for personal development[165]. Commitments and Compliance - The company has committed to fulfilling social security contributions as per legal requirements[130]. - The company has not faced any violations of commitments during the reporting period[130]. - The company has ongoing commitments to adhere to profit distribution policies as per relevant laws and regulations, with compliance in progress[128]. - The company has not reported any new significant related party transactions or commitments as of the latest disclosure[127]. - The company has confirmed that there are no financial transactions with related financial companies, ensuring independence in its operations[127].
康农种业(837403) - 监事会主席任命公告
2025-04-11 12:33
湖北康农种业股份有限公司监事会主席任命公告 本公司及监事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导 性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、任免基本情况 (一)任免的基本情况 证券代码:837403 证券简称:康农种业 公告编号:2025-024 公司新任董事、监事、高级管理人员候选人的任职资格符合法律法规、部门规章、 业务规则和公司章程等规定。本次任命未导致董事会中兼任高级管理人员的董事和由职 工代表担任的董事人数超过公司董事总数的二分之一。 本次任命不存在公司董事、高级管理人员兼任本公司监事的情形;不存在公司监事 为公司董事、高级管理人员的配偶、父母和子女情形。 (一)对公司生产、经营的影响: 根据《公司法》及《公司章程》的有关规定,公司第三届监事会第二十二次会议于 2025 年 4 月 10 日审议并通过《关于选举监事会主席的议案》。 任命郭春燕女士为公司监事会主席,任职期限至第三届监事会任期届满之日止,自 2025 年 4 月 10 日起生效。上述任命人员持有公司股份 65,000 股,占公司股本的 0.09%, 不是失信联合惩戒对象。 ( ...